Chengdu Kanghua Biological Products Co Ltd
SZSE:300841

Watchlist Manager
Chengdu Kanghua Biological Products Co Ltd Logo
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Watchlist
Price: 73.09 CNY Market Closed
Market Cap: ¥9.5B

Profitability Summary

Chengdu Kanghua Biological Products Co Ltd's profitability score is 52/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score
52/100
Profitability
Score

Margins

Earnings Waterfall
Chengdu Kanghua Biological Products Co Ltd

Margins Comparison
Chengdu Kanghua Biological Products Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
9.5B CNY
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
395.2B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.6B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.8B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Chengdu Kanghua Biological Products Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
9.5B CNY
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
395.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.6B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.8B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Chengdu Kanghua Biological Products Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate